Human Neural stem cell (HNSC) Transplant Location dependent neuroprotection and motor deficit amelioration in rats with penetrating TBI (PTBI).
Penetrating traumatic brain injury (PTBI) induced chronic inflammation that drives persistent tissue loss long after injury. Absence of endogenous reparative neurogenesis and effective neuroprotective therapies render injury-induced disability an unmet need. Cell replacement via neural stem cell transplantation could potentially rebuild the tissue and alleviate PTBI disability. The optimal transplant location remains to be determined. To test if subacute human neural stem cells (hNSCs) transplant location influences engraftment, lesion expansion, and motor deficits, rats (n=10/group) were randomized to following four groups (uninjured and three injured). Gr1: uninjured rats with cell transplants (sham+hNSCs), one-week post-unilateral pTBI, after establishing motor deficit, Gr2 was treated with vehicle (media, no cells), Gr3 hNSCs were transplanted into lesion core (intra), or in Gr4, tissue surrounding the lesion (peri). All animals were immunosuppressed for twelve weeks and euthanized following motor assessment. In Gr2, pTBI injury effect manifest as porencephalic cyst, 22.53±2.87 (% of intact hemisphere), with p-value <0.0001 compared to uninjured Gr1. Gr3 lesion volume at 17.44±2.11 did not differ significantly from Gr2 (p=0.36) while Gr4 value, 9.17±1.53 differed significantly (p=0.0001). Engraftment and neuronal differentiation were significantly lower in the uninjured Gr1 (p<0.05), compared to injured groups. However, there were no differences between Gr3 and G4. Significant increase in cortical tissue sparing (p=0.03), including motor cortex (p=0.005) was observed in Gr4 but not Gr3. Presence of transplant within lesion or in penumbra attenuated motor deficit development (p<0.05) compared to Gr2. In aggregate, injury milieu supports transplanted cell proliferation and differentiation independent of location. Unexpectedly, cortical sparing is transplant location dependent. Thus, apart from cell replacement and transplant mediated deficit amelioration, transplant location dependent neuroprotection may be key to delaying onset or preventing development of injury-induced disability. Preclinical study evaluation of therapeutic intervention, Level VI.